JP2014532710A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532710A5
JP2014532710A5 JP2014540070A JP2014540070A JP2014532710A5 JP 2014532710 A5 JP2014532710 A5 JP 2014532710A5 JP 2014540070 A JP2014540070 A JP 2014540070A JP 2014540070 A JP2014540070 A JP 2014540070A JP 2014532710 A5 JP2014532710 A5 JP 2014532710A5
Authority
JP
Japan
Prior art keywords
composition
use according
family
genus
ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014540070A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532710A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/063008 external-priority patent/WO2013067146A1/en
Publication of JP2014532710A publication Critical patent/JP2014532710A/ja
Publication of JP2014532710A5 publication Critical patent/JP2014532710A5/ja
Pending legal-status Critical Current

Links

JP2014540070A 2011-11-04 2012-11-01 健康を促進するための胃腸細菌を調節する方法及び組成物 Pending JP2014532710A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161555800P 2011-11-04 2011-11-04
US61/555,800 2011-11-04
PCT/US2012/063008 WO2013067146A1 (en) 2011-11-04 2012-11-01 Methods and compositions for modulating gastrointestinal bacteria to promote health

Publications (2)

Publication Number Publication Date
JP2014532710A JP2014532710A (ja) 2014-12-08
JP2014532710A5 true JP2014532710A5 (cg-RX-API-DMAC7.html) 2015-12-17

Family

ID=48192757

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014540070A Pending JP2014532710A (ja) 2011-11-04 2012-11-01 健康を促進するための胃腸細菌を調節する方法及び組成物

Country Status (11)

Country Link
US (1) US20150209383A1 (cg-RX-API-DMAC7.html)
EP (1) EP2773357A4 (cg-RX-API-DMAC7.html)
JP (1) JP2014532710A (cg-RX-API-DMAC7.html)
KR (1) KR20140093252A (cg-RX-API-DMAC7.html)
CN (1) CN104159588A (cg-RX-API-DMAC7.html)
AU (1) AU2012332491A1 (cg-RX-API-DMAC7.html)
BR (1) BR112014010660A2 (cg-RX-API-DMAC7.html)
CA (1) CA2854398A1 (cg-RX-API-DMAC7.html)
IN (1) IN2014CN04055A (cg-RX-API-DMAC7.html)
MX (1) MX2014005433A (cg-RX-API-DMAC7.html)
WO (1) WO2013067146A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201312713D0 (en) * 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption
GB2551642B (en) 2014-10-31 2020-09-23 Pendulum Therapeutics Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
EP3283087A4 (en) * 2015-04-14 2019-03-13 Ubiome Inc. METHOD AND SYSTEM FOR MICROBIOMEDIVED DIAGNOSTICS AND THERAPEUTICS FOR DISEASES OF THE ENDOCRINE SYSTEM
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
GB201519088D0 (en) * 2015-10-28 2015-12-09 Metabogen Ab The use of bacteria formulations
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
CN106994136A (zh) * 2016-01-26 2017-08-01 富士胶片株式会社 肠内细菌数量抑制剂、食品、及药品
SG11201807616RA (en) * 2016-03-14 2018-10-30 B Food Science Co Ltd Proliferative agent for faecalibacterium
EP3511406A4 (en) * 2016-09-06 2020-04-01 BGI Shenzhen FAECALIBACTERIUM LONGUM AND APPLICATION THEREOF
EP3630146A1 (en) 2017-06-02 2020-04-08 Goodgut S.L. Grape skin for use in the treatment of dysbiosis
AU2018326705A1 (en) 2017-08-30 2020-03-05 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
EP3466417A1 (en) * 2017-10-04 2019-04-10 Sorbonne Université Compounds for the prevention and treatment of glucose intolerance related conditions and obesity
CA3088630A1 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
CN109998112B (zh) * 2017-12-22 2024-05-14 奥地利商艾尔柏有限公司 红蝽杆菌纲促进肠道健康的用途
EP3752167A1 (en) * 2018-02-14 2020-12-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Polydextrose for the treatment of inflammatory diseases
EP3790997A4 (en) * 2018-05-09 2022-03-16 Carbiotix AB METHOD FOR MEASURING AND IMPROVING INTESTINAL HEALTH
US11376289B2 (en) 2018-05-31 2022-07-05 Bgi Shenzhen Composition and uses thereof
CA3106315A1 (en) 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
CA3111795A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
ES2763874B2 (es) * 2018-11-30 2020-10-13 Consejo Superior Investigacion Phascolarctobacterium faecium para su uso en la prevencion y tratamiento de la obesidad y sus comorbilidades
EP4041264A1 (en) * 2019-10-07 2022-08-17 Siolta Therapeutics, Inc. Therapeutic pharmaceutical compositions
KR102174095B1 (ko) * 2019-12-11 2020-11-05 주식회사 에이치이엠 신규한 엔테로코커스 패시움 hem 200 균주, 및 상기 균주 또는 이의 배양물을 포함하는 장내 환경 개선용 조성물
WO2021184008A1 (en) * 2020-03-13 2021-09-16 Fitbiomics Inc. Probiotic compositions for improving human health and athletic performance
JP2021168651A (ja) * 2020-04-16 2021-10-28 サンスター株式会社 フィーカリバクテリウム属細菌増殖用組成物、酪酸産生増加用組成物、及び腸内環境改善用組成物
JP2024518270A (ja) * 2021-05-06 2024-05-01 ソシエテ・デ・プロデュイ・ネスレ・エス・アー イノシトール、エリスリトール、又はソルビトールのうちの少なくとも1つを使用した、フィーカリバクテリウム・プラウスニッツィイの生育を増進するための組成物及び方法
WO2023092150A1 (en) 2021-11-22 2023-05-25 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0394655A (ja) * 1989-09-06 1991-04-19 Otsuka Pharmaceut Co Ltd 栄養補給用組成物
JP4328473B2 (ja) * 2001-04-09 2009-09-09 雪印乳業株式会社 肥満予防改善飲食品
FI20020078A7 (fi) * 2002-01-15 2003-07-16 Danisco Immuunijärjestelmän stimulointi polydextroosilla
JP2003334025A (ja) * 2002-05-15 2003-11-25 Toyo Shinyaku:Kk 健康食品
JP2005534315A (ja) * 2002-08-06 2005-11-17 ダニスコ エイ/エス 食品および薬学的組成物中に細胞外多糖類を産生する乳酸桿菌の使用
GB0302872D0 (en) * 2003-02-10 2003-03-12 Univ Liverpool Treatment of inflammatory bowel disease
US20080292766A1 (en) * 2007-05-23 2008-11-27 Hoffman Andrew J Edible Composition Comprising a Slowly Digestible or Digestion Resistant Oligosaccharide Composition
GB0903016D0 (en) * 2009-02-23 2009-04-08 Univ Gent Method for alleviating intestinal problems and novel bacterial strains therefor
US8816067B2 (en) * 2009-05-07 2014-08-26 Tate & Lyle Ingredients France SAS Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans

Similar Documents

Publication Publication Date Title
JP2014532710A5 (cg-RX-API-DMAC7.html)
BR112016018013A2 (pt) Preparação e incorporação de coprodutos em bebidas para alcançar benefícios de saúde metabólica e do tubo digestivo
JP2010195825A5 (cg-RX-API-DMAC7.html)
TWD144864S (zh) 拉鏈用鏈條
JP2009537554A5 (cg-RX-API-DMAC7.html)
JP2016501862A5 (cg-RX-API-DMAC7.html)
Zhao et al. Advanced development in analysis of phytochemicals from medicine and food dual purposes plants used in China
JP2022105649A5 (cg-RX-API-DMAC7.html)
WO2014085453A3 (en) Small molecule lxr inverse agonists
BR112012015637A2 (pt) "macarrão instantâneo frito em óleo contendo ferro e seu processo de preparação"
BRPI1015300A2 (pt) "composição nutricional compreendendo um extrato de maçã e reduzindo os sintomas de alegria a alimentos, especialmente em crianças"
HRP20191356T1 (hr) Fitoegdizoni, namijenjeni upotrebi u poboljšavanju kvalitete mišića pretilih i sarkopeničnih sisavaca
WO2011031166A3 (en) Fish feed
JP2012100550A5 (cg-RX-API-DMAC7.html)
CN104689208A (zh) 一种用于健胃护肝的中药组合物
WO2009108067A3 (en) Fatty acid derivatives for use in the prevention and treatment of hsmi
HRP20161166T1 (hr) Tapentadol za uporabu u liječenju sindroma iritabilnog crijeva
CN302205230S (zh) 糖食
TH45603S1 (th) ผ้าอนามัย
CN301581846S (zh) 蛋糕柜
GB201205145D0 (en) A composition for reducing the consumption of food and the absorption of its lipid constituents
TH154745A (th) องค์ประกอบเกลือของโลหะ
TH114343S (th) ผ้าอนามัย
TH41670S1 (th) ผ้าอนามัย
TH114344S (th) ผ้าอนามัย